Treatment of Advanced Urothelial Carcinoma with M-VECA (Methotrexate, Vinblastine, Epirubicin and Carboplatin)
Vito Lorusso(Istituto Tumori Bari), M. De Lena(Istituto Tumori Bari), Francesco Paolo Selvaggi(Santa Maria Nuova Hospital), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Arcangelo Pagliarulo(Policlinico Universitario di Catania), P. Comella, Chiara Fiorillo(Fondazione Stella Maris), Ernesto Durini(Ito Hospital)
Cited by 5
Related Papers
Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2000|452
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial
|Journal of Clinical Oncology|2012|234
Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
|Journal of Clinical Oncology|2017|186
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study
|The Journal of Clinical Endocrinology & Metabolism|2019|180